chr10-93587284-G-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001195755.2(FFAR4):​c.761G>A​(p.Arg254His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0174 in 1,614,070 control chromosomes in the GnomAD database, including 393 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.014 ( 39 hom., cov: 31)
Exomes 𝑓: 0.018 ( 354 hom. )

Consequence

FFAR4
NM_001195755.2 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1O:1

Conservation

PhyloP100: 1.75
Variant links:
Genes affected
FFAR4 (HGNC:19061): (free fatty acid receptor 4) This gene encodes a G protein-coupled receptor (GPR) which belongs to the rhodopsin family of GPRs. The encoded protein functions as a receptor for free fatty acids, including omega-3, and participates in suppressing anti-inflammatory responses and insulin sensitizing. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002275765).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0143 (2180/152256) while in subpopulation SAS AF = 0.0399 (192/4810). AF 95% confidence interval is 0.0353. There are 39 homozygotes in GnomAd4. There are 1061 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 39 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FFAR4NM_001195755.2 linkc.761G>A p.Arg254His missense_variant Exon 3 of 3 ENST00000371481.9 NP_001182684.1 Q5NUL3-2B4DWG6
FFAR4NM_181745.4 linkc.809G>A p.Arg270His missense_variant Exon 4 of 4 NP_859529.2 Q5NUL3-1B4DWG6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FFAR4ENST00000371481.9 linkc.761G>A p.Arg254His missense_variant Exon 3 of 3 1 NM_001195755.2 ENSP00000360536.5 Q5NUL3-2
FFAR4ENST00000371483.8 linkc.809G>A p.Arg270His missense_variant Exon 4 of 4 1 ENSP00000360538.4 Q5NUL3-1
FFAR4ENST00000604414.1 linkc.696+11065G>A intron_variant Intron 2 of 2 3 ENSP00000474477.1 S4R3L2

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2183
AN:
152138
Hom.:
39
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00352
Gnomad AMI
AF:
0.124
Gnomad AMR
AF:
0.00772
Gnomad ASJ
AF:
0.0701
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0403
Gnomad FIN
AF:
0.0103
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0181
Gnomad OTH
AF:
0.00958
GnomAD2 exomes
AF:
0.0183
AC:
4592
AN:
251378
AF XY:
0.0200
show subpopulations
Gnomad AFR exome
AF:
0.00314
Gnomad AMR exome
AF:
0.00532
Gnomad ASJ exome
AF:
0.0601
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0115
Gnomad NFE exome
AF:
0.0207
Gnomad OTH exome
AF:
0.0196
GnomAD4 exome
AF:
0.0177
AC:
25835
AN:
1461814
Hom.:
354
Cov.:
33
AF XY:
0.0187
AC XY:
13563
AN XY:
727218
show subpopulations
Gnomad4 AFR exome
AF:
0.00248
AC:
83
AN:
33478
Gnomad4 AMR exome
AF:
0.00610
AC:
273
AN:
44724
Gnomad4 ASJ exome
AF:
0.0633
AC:
1653
AN:
26134
Gnomad4 EAS exome
AF:
0.0000252
AC:
1
AN:
39696
Gnomad4 SAS exome
AF:
0.0345
AC:
2974
AN:
86256
Gnomad4 FIN exome
AF:
0.0111
AC:
594
AN:
53416
Gnomad4 NFE exome
AF:
0.0171
AC:
18975
AN:
1111946
Gnomad4 Remaining exome
AF:
0.0188
AC:
1136
AN:
60396
Heterozygous variant carriers
0
1456
2912
4369
5825
7281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
716
1432
2148
2864
3580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0143
AC:
2180
AN:
152256
Hom.:
39
Cov.:
31
AF XY:
0.0143
AC XY:
1061
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.00351
AC:
0.00351418
AN:
0.00351418
Gnomad4 AMR
AF:
0.00771
AC:
0.0077104
AN:
0.0077104
Gnomad4 ASJ
AF:
0.0701
AC:
0.0700692
AN:
0.0700692
Gnomad4 EAS
AF:
0.000193
AC:
0.000193199
AN:
0.000193199
Gnomad4 SAS
AF:
0.0399
AC:
0.0399168
AN:
0.0399168
Gnomad4 FIN
AF:
0.0103
AC:
0.0102656
AN:
0.0102656
Gnomad4 NFE
AF:
0.0181
AC:
0.0181123
AN:
0.0181123
Gnomad4 OTH
AF:
0.00948
AC:
0.00947867
AN:
0.00947867
Heterozygous variant carriers
0
104
209
313
418
522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0185
Hom.:
98
Bravo
AF:
0.0133
TwinsUK
AF:
0.0148
AC:
55
ALSPAC
AF:
0.0145
AC:
56
ESP6500AA
AF:
0.00477
AC:
21
ESP6500EA
AF:
0.0174
AC:
150
ExAC
AF:
0.0193
AC:
2342
Asia WGS
AF:
0.0130
AC:
45
AN:
3478
EpiCase
AF:
0.0192
EpiControl
AF:
0.0212

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10 Uncertain:1Other:1
May 07, 2024
Clinical Genomics Laboratory, Washington University in St. Louis
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The FFAR4 c.761G>A (p.Arg254His) variant, also reported as NM_181745.4:c.809G>A (p.Arg270His), has been reported as a risk allele for obesity with an odds ratio of 1.62; 95% CI 1.31-2.00 (Ichimura A et al., PMID: 22343897) and a risk allele for pathologic ALT levels with an odds ratio of 3.2, 95% CI 1.3-8.0 (adjusted for age, sex, and BMI SDS) (Marzuillo P et al., PMID: 25250621). The highest population minor allele frequency in the population database genome aggregation database (v2.1.1) is 6.03% in the Ashkenazi Jewish population. This variant may increase risk for obesity and elevated ALT levels along with other genetic and environmental factors; based on available information and the ClinGen Low Penetrance/Risk Allele Working Group recommendations (Schmidt RJ et al., PMID: 38054408) this variant is classified as an uncertain risk allele. -

Feb 19, 2012
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.051
.;T
Eigen
Benign
-0.028
Eigen_PC
Benign
0.091
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.79
T;T
MetaRNN
Benign
0.0023
T;T
MetaSVM
Benign
-0.73
T
MutationAssessor
Benign
2.0
.;M
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.8
N;N
REVEL
Benign
0.20
Sift
Benign
0.053
T;T
Sift4G
Benign
0.15
T;T
Polyphen
0.070
B;B
Vest4
0.11
MPC
0.77
ClinPred
0.013
T
GERP RS
5.0
Varity_R
0.12
gMVP
0.62
Mutation Taster
=85/15
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116454156; hg19: chr10-95347041; COSMIC: COSV65160232; COSMIC: COSV65160232; API